PROMEDCO MANAGEMENT CO
NT 10-Q, 2000-11-15
OFFICES & CLINICS OF DOCTORS OF MEDICINE
Previous: MEDICAL INFORMATION TECHNOLOGY INC, 10-Q, 2000-11-15
Next: WELLS FARGO ASSET SECURITIES CORP, 8-K, 2000-11-15





                               UNITED STATES
                    SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C. 20549

                                FORM 12b-25

                            Commission File Number 0-29172

                            NOTIFICATION OF LATE FILING

(Check One): [  ] Form 10-K [  ] Form 20-F [  ] Form 11-K [X] Form 10-Q
             [  ] Form N-SAR

         For Period Ended: September 30, 2000

         [  ] Transition Report on Form 10-K
         [  ] Transition Report on Form 20-F
         [  ] Transition Report on Form 11-K
         [  ] Transition Report on Form 10-Q
         [  ] Transition Report on Form N-SAR

         For the Transition Period Ended:___________________________

Read  Instruction (on back page) Before  Preparing  Form.  Please Print or Type.
Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:


PART 1 - REGISTRANT INFORMATION

Full Name of Registrant:                    ProMedCo Management Company

Former Name if Applicable:

Address of Principal Executive Office:       801 Cherry Street, Suite 3200

City, State and Zip Code:                   Fort Worth, Texas  76102



<PAGE>





PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

[X]               (a) The reasons  described  in  reasonable  detail in Part III
                  of this form  could  not be  eliminated  without unreasonable
                  effort or expense;

[X]               (b) The subject annual report,  semi-annual report, transition
                  report on Form 10-K,  Form 20-F,  11-K, Form N-SAR, or portion
                  thereof, will be filed on or before the fifteenth calendar day
                  following the  prescribed  due date; or the subject  quarterly
                  report of transition  report on Form 10-Q, or portion  thereof
                  will be filed on or before the fifth  calendar  day  following
                  the prescribed due date; and

[  ]              (c)      The accountant's statement or other exhibit required
                  by Rule 12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in  reasonable  detail the reasons  why the Form 10-K,  11-K,  10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed)

The Company requires additional time to prepare and file its quarterly report on
Form  10-Q  for the  quarter  ended  September  30,  2000 in  order  to  reflect
developments  occurring immediately prior to the required filing date, including
the fact that the Company has not completed its continuing  efforts to negotiate
an amendment to its credit  facility under which the lending banks would,  among
other things, waive the Company's breaches of certain credit agreement covenants
during the quarter and establish a new level of permitted future borrowings. The
Company expects to conclude negotiations with the banks shortly,  although there
can be no assurance that such negotiations will be successful.

PART IV - OTHER INFORMATION

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
notification.

Robert D. Smith                         (817)                 335-5035
(Name)                                 (Area Code)      (Telephone Number)

(2) Have all other  periodic  reports  required under Section 13 or 15(d) of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during  the  preceding  12  months  or for such  shorter  period  that the
registrant  was  required to file such  report(s)  been filed?  If answer is no,
identify report(s). [X] Yes [ ] No

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings statements to be included in the subject report or portion thereof?
[X]Yes     [ ]No

If so, attach an explanation of the anticipated  change,  both narratively,  and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.


The Company  anticipates  reporting net losses of approximately  $48 million and
$45  million  for the  three and nine  months  ended  September  30,  2000,  due
primarily to restructuring charges of approximately $60.8 million resulting from
(i) the Company's  conversion  to a new  affiliation  structure  with one of its
medical  groups,  (ii) its decision to exit  another of its  markets,  (iii) the
shutdown  of a site  in a third  market,  and  (iv)  the  reorganization  of its
subsidiary that provides capitation management services.

                           ProMedCo Management Company
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.




Date:  November 15, 2000                        By:  /s/ ROBERT D. SMITH
                                                          Robert D. Smith
                                                Senior Vice President - Finance


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission